Synchronoss Technologies Inc. (SNCR) is not a good buy for a beginner, long-term investor at this time. The company's financial performance has significantly deteriorated, with revenue, net income, and EPS showing steep declines. Additionally, there are no strong positive catalysts, and the technical indicators, while showing bullish moving averages, lack clear confirmation for a strong upward trend. Options data and trading trends also do not indicate significant bullish sentiment. Given the lack of positive momentum and weak financials, holding off on investment is recommended.

Technical Analysis

The MACD is negative and contracting, indicating bearish momentum. RSI is neutral at 75.657, not signaling overbought or oversold conditions. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), but this is not strongly supported by other indicators. Key resistance is at 9.051, with support at 8.729.

Options Data

Bearish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Technical Summary

Sell

Buy

Positive Catalysts

NULL identified. No recent news or significant trading trends to suggest positive momentum.

Neutral/Negative Catalysts

The company's financial performance has significantly deteriorated in Q3 2025, with revenue, net income, and EPS showing steep YoY declines. No recent news or trading trends suggest a turnaround.

Financial Performance

In Q3 2025, revenue dropped by -2.24% YoY to $42,003,000. Net income plummeted by -201.96% YoY to $5,813,000. EPS fell by -191.07% YoY to 0.51. Gross margin slightly decreased by -0.20% YoY to 68.76%. Overall, the financial performance is weak.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No recent analyst ratings or price target changes available.

1 Analyst Rating

Wall Street analysts forecast SNCR stock price to rise

0 Buy

1 Hold

0 Sell

Hold

Current: 9.000

Low

Averages

High

Current: 9.000

Low

Averages

High

Roth Capital

Richard Baldry

Buy

downgrade

$13 -> $10

AI Analysis

2025-11-06

Reason

Roth Capital

Richard Baldry

Price Target

$13 -> $10

AI Analysis

2025-11-06

downgrade

Buy

Reason

Roth Capital analyst Richard Baldry lowered the firm's price target on Synchronoss to $10 from $13 and keeps a Buy rating on the shares. The company's streamlined operations and elevated EBITDA levels of 2024 have been largely defended in 2025, with Q3 EBITDA of $12.0M only marginally below the $12.7M average of the prior six quarters, the analyst tells investors in a research note.

Roth Capital

Buy

downgrade

$13 -> $10

2025-11-05

Reason

Roth Capital

Price Target

$13 -> $10

2025-11-05

downgrade

Buy

Reason

Roth Capital lowered the firm's price target on Synchronoss to $10 from $13 and keeps a Buy rating on the shares. Q3 revenues of $42.0M were modestly below the firm's $43.0M forecast, while Q3 AEBITDA of $12.0M was "only marginally below" the $12.7M average of the prior six quarters, notes the analyst, who cites "still challenged growth" for the firm's lowered price target.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for SNCR

Unlock Now

SNCR Should I Buy

SNCR Should I Buy

Should You Buy Synchronoss Technologies Inc (SNCR) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch